FPHAX
Fidelity Select Pharmaceuticals
1W: -3.1%
1M: -4.6%
3M: -3.6%
YTD: +9.7%
1Y: +20.3%
3Y: +61.9%
5Y: +77.4%
$33.86
-0.06 (-0.18%)
Weekly Expected Move ±2.5%
$32
$33
$34
$35
$36
Portfolio Health Summary
IS Overall Score
57.5
★★★★★
Altman Z-Score
854.00
Safe
Weight Coverage
97%
of portfolio analyzed
Holdings Matched
42
with fundamental data
InsiderStreet Scorecard
★★★★★
57.5
Top Holdings: Score Breakdown
Risk & Quality Signals
Altman Z-Score
854.00
Safe Zone (>2.99)
Piotroski F-Score
6.1 / 9
Moderate
Beneish M-Score
-1.77
Possible Manipulator
Credit Score
—
Earnings Quality
57.9 / 100
Portfolio Valuation
P/E
27.46x
P/B
11.71x
P/S
6.80x
EV/EBITDA
20.96x
EV/Revenue
9.20x
P/FCF
30.46x
P/OCF
22.19x
PEG
1.03x
Earnings Yield
3.64%
FCF Yield
3.28%
OCF Yield
4.51%
Median P/E
-6.12x
Growth & Shareholder Returns
Year-over-Year Growth
Revenue
+20.6%
Net Income
+43.1%
EPS
+46.0%
FCF
+72.2%
EBITDA
+60.9%
Op. Income
—
Compound Growth Rates
Rev CAGR 3Y
+20.4%
Rev CAGR 5Y
+19.1%
EPS CAGR 3Y
+26.7%
EPS CAGR 5Y
+21.6%
FCF CAGR 3Y
+37.9%
FCF CAGR 5Y
+21.1%
EBITDA CAGR 3Y
+30.6%
EBITDA CAGR 5Y
+19.2%
Payout Ratio
49.86%
Buyback Yield
0.36%
Dividend Yield
1.32%
Total Shareholder Return
-1.42%
Earnings Stability
Monte Carlo Price Simulation
Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.
Current Price
$33.92
Median 1Y
$37.97
5th Pctile
$28.00
95th Pctile
$51.93
Ann. Volatility
19.5%
25th–75th percentile
5th–95th percentile
Median path
Historical
All Ratios & Metrics
Valuation (12)
| Metric | Value |
|---|---|
| Portfolio P/E | 27.46 |
| Portfolio P/B | 11.71 |
| Portfolio P/S | 6.80 |
| EV/EBITDA | 20.96 |
| EV/Revenue | 9.20 |
| P/FCF | 30.46 |
| P/OCF | 22.19 |
| PEG | 1.03 |
| Earnings Yield | 3.64% |
| FCF Yield | 3.28% |
| OCF Yield | 4.51% |
| Median P/E | -6.12 |
Profitability & Returns (9)
| Metric | Value |
|---|---|
| Gross Margin | 78.79% |
| Operating Margin | 36.03% |
| Net Margin | 23.57% |
| FCF Margin | 22.21% |
| ROE | 45.49% |
| ROA | 13.98% |
| ROIC | 27.00% |
| ROCE | — |
| Asset Turnover | — |
Leverage & Solvency (6)
| Metric | Value |
|---|---|
| Debt/Equity | 1.08 |
| Debt/Assets | 0.34 |
| Net Debt/EBITDA | 1.10 |
| Interest Coverage | 24.09 |
| Current Ratio | 1.24 |
| Quick Ratio | 0.92 |
Efficiency (4)
| Metric | Value |
|---|---|
| Asset Turnover | — |
| Inventory Turnover | — |
| Receivables Turnover | — |
| Payables Turnover | — |
Growth — YoY (6)
| Metric | Value |
|---|---|
| Revenue Growth | 20.60% |
| Net Income Growth | 43.08% |
| EPS Growth | 45.98% |
| FCF Growth | 72.17% |
| EBITDA Growth | 60.93% |
| Op. Income Growth | — |
Growth — CAGR (16)
| Metric | Value |
|---|---|
| Revenue CAGR 3Y | 20.38% |
| Revenue CAGR 5Y | 19.11% |
| Revenue CAGR 10Y | — |
| EPS CAGR 3Y | 26.65% |
| EPS CAGR 5Y | 21.63% |
| EPS CAGR 10Y | — |
| FCF CAGR 3Y | 37.88% |
| FCF CAGR 5Y | 21.05% |
| FCF CAGR 10Y | — |
| EBITDA CAGR 3Y | 30.59% |
| EBITDA CAGR 5Y | 19.23% |
| EBITDA CAGR 10Y | — |
| Net Income CAGR 3Y | 25.64% |
| Net Income CAGR 5Y | 21.83% |
| Op. Income CAGR 3Y | — |
| Op. Income CAGR 5Y | — |
Quality Scores (13)
| Metric | Value |
|---|---|
| IS Overall | 57.5 |
| IS Profitability | 66.7 |
| IS Balance Sheet | 54.5 |
| IS Earnings Quality | 57.9 |
| IS Growth | 59.9 |
| IS Value | 46.0 |
| IS Momentum | 74.0 |
| IS Safety | 83.9 |
| IS Quality | 69.1 |
| Altman Z-Score | 854.00 |
| Piotroski F-Score | 6.11 |
| Beneish M-Score | -1.77 |
| Credit Score | — |
Dividends & Payout (4)
| Metric | Value |
|---|---|
| Dividend Yield | 1.32% |
| Payout Ratio | 49.86% |
| Buyback Yield | 0.36% |
| Total Shareholder Return | -1.42% |
Growth Stability (4)
| Metric | Value |
|---|---|
| Revenue Stability | 0.662 |
| Earnings Stability | 0.420 |
| Earnings Persistence | 0.655 |
| Margin Stability | 0.837 |
Medians (3)
| Metric | Value |
|---|---|
| Median P/E | -6.12 |
| Median P/B | 4.26 |
| Median Dividend Yield | — |
Coverage Meta (3)
| Metric | Value |
|---|---|
| Weight Coverage % | 97.45% |
| Holdings Matched | 42 |
| Total Holdings | 44 |